Company Profile
Endo Peace Biomedical Technology Co., Ltd. is a Taiwan-based clinical-stage developer of GI endoscopy hemostasis systems, headquartered in Tainan, Taiwan. Founded on September 27, 2023 by Professor Xi-Zhang Lin (Hsi-Chang Lin) of National Cheng Kung University (NCKU) College of Medicine, the company operates as an independent private entity and university spin-off, serving global gastroenterology and interventional oncology markets with award-winning device platforms.
Core Products ＆ Technologies
GI Endoscopy Hemostasis
• FP Spray System (GI Hemo-stop Powder ＆ Delivery Device): Functional powder spray system paired with endoscopes for non-invasive GI tract hemostasis; 18th National Innovation Award winner
• T-ACE Oil: Intrahepatic cholangiocarcinoma new-system drug and device combination for targeted oncology therapy
Regenerative Biomaterials
• EZECZBONE Technology: Electrospun biomedical materials for nerve system repair and regenerative medicine applications
Market Position ＆ Certifications
Endo Peace Biomedical holds an emerging innovator position in the Asia-Pacific GI endoscopy accessories market, developing alternatives to Boston Scientific (Hemospray) and Olympus endoscopy platforms. Key strengths include:
• 3 years of Taiwan clinical-academic R＆D heritage since founding
• Dual-award recognition: 18th National Innovation Award - Clinical Innovation and Future Tech Award (2023)
• Sustained innovation: 2025 National Innovation Excel Award for continued R＆D advancement
• Regulatory status: Clinical-stage devices undergoing validation; Taiwan MOHW registration pathway in progress
• Academic collaboration: Direct technology transfer from NCKU Hospital clinical practice
Corporate Timeline
2023 — Founded on September 27 in Tainan, Taiwan, as NCKU spin-off
2023 — Won 18th National Innovation Award (Clinical Innovation) for GI hemostasis powder system
2023 — Won Future Tech Award for FP Spray System
2023 — Served as invited faculty and Hands-on Workshop unit at APDW 2023 Bangkok
2024 — Exhibited at KDDW 2024 (Korea Digestive Disease Week) in Seoul
2025 — Won National Innovation Excel Award for continued product refinement
2025 — Exhibited at TDDW 2025 (Taiwan Digestive Disease Week) in Taipei
2026 — Exhibited at BIO International Convention (BIO Square) in San Diego
Target Markets ＆ Applications
• Upper GI Bleeding (UGIB): FP Spray System for endoscopic hemostasis in gastric and duodenal bleeding
• Hepatobiliary Oncology: T-ACE Oil device-drug system for intrahepatic cholangiocarcinoma intervention
• Regenerative Medicine: EZECZBONE electrospun materials for peripheral nerve repair
Contact Information
Global Headquarters
Address: 4F., Tech Building, Tzu-Chiang Campus, No. 1, Daxue Rd., East Dist., Tainan City 701, Taiwan
Telephone: +886 6 208 4009
Email: endopeacebio@gmail.com
Corporate Status
Entity Type: Independent Private Company (No Parent Company)
Stock: Not Publicly Traded
Website: endo-peacebio.com.tw
